Terumo Establishes New Group Identity Institutes "Core Values" to be Shared by All Associates
TOKYO, JAPAN - April 1, 2019 - Terumo Corporation (TSE: 4543) today established an enhanced group identity that consists of three elements: The existing "Group Mission," the newly instituted "Core Values," and the revised "Terumo Group Code of Conduct."
Terumo will celebrate its 100th anniversary in 2021. Since its 1921 founding, Terumo Group, under its group mission of "Contributing to Society through Healthcare," has provided products and services to serve the needs of ever-changing medical settings, earning the trust of patients and medical professionals. Terumo now employs approximately 25,000 associates and includes approximately 100 group companies. The external environment surrounding Terumo is also changing greatly; IT and biotechnology are evolving dramatically, while globalization further advances. Amid these global changes, Terumo has officially established Core Values to continually earn the trust of the global market and serve as a foundation for its ongoing growth; they will be shared by and connect Terumo associates worldwide. The Core Values will drive Terumo overall strengths across businesses and regions, serving to guide associates in making challenging decisions as they carry out their work. The Terumo Group Code of Conduct has also been revised in conjunction with the establishment of the Core Values. The Code of Conduct shows the standards of conduct which all associates should comply, and it guides all associates to doing the right things with holding themselves to the highest ethical standards.
As each of its associates conducts business activities according to this enhanced group identity, Terumo will further strive to be of value to patients, medical professionals, and society at large.
- Group Mission
Contributing to Society through Healthcare
- Core Values
Respect - Appreciative of others
We show respect and appreciation toward associates, customers, and business partners. We value individuality and diverse cultures, and listen widely and carefully to different opinions and the voice of society.
Integrity - Guided by our mission
As associates of Terumo Group, responsible for life and health, we always act with sincerity and a sense of mission. Through our daily efforts, we build trust among all stakeholders.
Care - Empathetic to patients
We are mindful that everything we do ultimately connects us to patients. We strive to understand health providers deeply and work together with them to give patients a better future.
Quality - Committed to excellence
To ensure safety and reliability in healthcare, we view each issue from a "gemba" perspective in order to find the optimal solution. As well as product quality, we pursue excellence in all we do, from product supply to customer care.
Creativity - Striving for innovation
We promote a mindset that embraces challenge for the future, and work with curiosity and passion. We respond to the needs of "gemba" by delivering products and services that create meaningful value in a timely manner.
- Terumo Group Code of Conduct
The Code of Conduct shows the standards of conduct which all associates should comply, and it guides all associates to doing the right things with holding themselves to the highest ethical standards.
Regarding the Terumo Group Identity, please see the below website.
About Terumo Corporation
Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers, with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices, including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician-office use. Terumo contributes to society by providing valued products and services to the health care market, and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.
(Notice) Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition. The market share information in this press release is partly derived from our own independent research.